True Diagnostics has obtained CE mark for TrueDXPSA, a quantitative prostate specific hormone (PSA) test. TrueDXPSA test will enable doctors to rapidly determine the PSA level in a patient. True Diagnostics president and CEO Jerry Lee ...
Tags: Diagnostics, clinical studies, health
Mystic Pharmaceuticals has obtained US patent for intranasal cartridge devices based on VersiDoser and VRx2 unit dose packaging and delivery platforms. The new device technology facilitates delivery of drugs and biologics into the body ...
Two billion tonnes of food never makes it on a plate – this was the headline that grabbed the nation’s attention mid-January, putting the food industry and its practices under the microscope again, re-igniting the debate on ...
Tags: Christopher McCuin, food, IME
Screenings for several forms of cancer, such as of the prostate and ovaries, get low marks in our new Ratings of cancer screening tests, because their risks clearly outweigh the benefits for most people. But the decision whether to get a ...
Tags: cancer, cancer screening tests, healthcare
At the Glass Association of North America’s (GANA) Annual Conference in San Diego yesterday, three unique industry-related perspectives from three different occupational fields discussed whether using less glass in building ...
Limited Brands, owner of iconic underwear labels Victoria’s Secret and La Senza, committed to eliminate all releases of hazardous chemicals throughout its global supply chain and across all of its brands and products by 2020, in ...
Aileron Therapeutics has secured the second tranche in its series D financing, meaning the overall total has now reached $42 million (pound 26 million). This payment followed the successful progression of the company's ALRN-5281 lead ...
Germany-based biotechnology company Sphingotec has introduced a simple blood test to quantify individual risk of developing breast cancer in women. The test, sphingotest pro-NT, enables gynecologists, family doctors and clinical ...
Tags: Germany, Sphingotec, blood test, individual risk, breast cancer
Having trouble sleeping? Gaining a bit of weight? Your smartphone or computer might be to blame. Actually, the problem is more likely about your obsession with your laptop and devices than the devices themselves. A new study from ...
Tags: Consumer Electronics, Smartphones, tablets
FINOX Biotech has submitted the Marketing Authorisation Application (MAA) for its biosimilar recombinant Follicle Stimulating Hormone (r-FSH) BEMFOLA to the European Medicines Agency. The submission was based on a comprehensive clinical ...
Tags: FINOX Biotech, Marketing Authorisation Application, Medicines, healthcare
NASA's planning a test to replace fluorescent lighting panels in the ISS with a solid-state LED lighting module which produces blue, white, or reddish light depending on the time. It hopes that this change will serve as a counter-measure ...
Nasa has committed to spend $11.2 million (£6.9 million) on developing a colour-changing LED system which will encourage astronauts to sleep by mimicking their natural circadian rhythms. It is hoped that the space agency’s ...
Tags: NASA, Circadian Lighting System, Lighting
High street fashion brands are selling clothing contaminated with hazardous chemicals that break down to form hormone-disrupting or even cancer-causing chemicals when released into the environment, according to a report released by ...
Tags: Greenpeace investigations, hazardous chemicals in clothing
Partners from research and industry are studying the principles of next-generation cabin lighting Gradual transitions from day into night have become standard today on board of modern passenger aircraft. Bergische Universität ...
Tags: cabin lighting, Osram, LED, flight tests, LED-based lighting
AstraZeneca and US Food and Drug Administration (FDA) have agreed to update label for Faslodex (fulvestrant) injection. The updated prescribing information for Faslodex US contains results and a Kaplan-Meier plot of the final overall ...
Tags: AstraZeneca, Faslodex injection label, US, FDA